| NEI Psychopharmacology Congress |
|
|
|
Violent Means: When Mental Illness and Aggressive Behavior Collide
Stephen M Stahl, MD, PhD
While most patients with mental illness are not violent, there is a subpopulation of dangerous patients who are at high risk for violent behavior and pose a significant problem for both themselves, and the clinicians who treat them. In this presentation, Dr. Stephen Stahl provides the most current research on genetic and environmental risk factors for various types of violent/aggressive behaviors in psychiatric patients, along with the most appropriate treatment strategies currently available.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Cultural Competence: Asian American Mental Health Issues and Practical Strategies
Rona J Hu, MD
Cultural differences can significantly influence several aspects of treating mental illness. In this presentation, Dr. Rona Hu provides information about how cultural differences can influence the patient’s attitude about their mental illness, their symptom expression, and their response to treatment, along with practical advice about how to effectively address cultural differences in your practice.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Lightning Round Cases: Impulsivity-Compulsivity and Binge Eating Disorder
Leslie L. Citrome, MD, MPH
Eating disorders can significantly influence several aspects of treating mental illness. In this presentation, Dr. Leslie Citrome provides information about the neurobiological mechanisms that underlie impulsive-compulsive behavior, such as eating disorders. He also shares the most current effective strategies for the treatment of binge eating disorder.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Lightning Round Cases: Opioid Therapy IS Associated With Abuse and Misuse: Tips to Manage It in Your Practice
Stephen M Stahl, MD, PhD
Opioid therapy has a place in chronic pain management when pain is severe and non-opioid treatments have been ineffective. However, prescription drug abuse is higher in the United States than anywhere in the world. In this presentation, Dr. Stephen Stahl discusses the most currently effective tools in assessing risk of misuse and abuse in patients prescribed opioid medications for chronic pain.
CME credit: 0.50
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Lightning Round Cases: Treatments for Opioid Dependence
Stephen M Stahl, MD, PhD
When it comes to recognizing and managing prescription drug abuse for patients, knowing the most current and effective treatment options available today can have a significant impact on recovery. In this presentation, Dr. Stephen Stahl provides the most cutting-edge research on current treatment options for prescription opioid dependence.
CME credit: 0.50
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Ultra High Clinical Risk for Psychosis: The State of the Evidence
Rona J Hu, MD
Due to genetic and environmental factors some individuals are at ultra-high risk for developing schizophrenia. In this presentation, Dr. Rona Hu provides the most current research on genetic and environmental risk factors for schizophrenia, along with the most appropriate treatment strategies currently available.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
First-episode Schizophrenia: Setting the Stage for Successful Outcomes
Rona J Hu, MD
Optimizing treatment of first-episode schizophrenia is not just about controlling psychotic symptoms acutely, but also setting the stage for successful long-term outcomes by minimizing side effects and optimizing access to psychosocial treatment strategies. Dr. Rona Hu offers a practical perspective on strategies that should be implemented beginning with the first episode in order to optimize a patient's opportunity for a satisfying life.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Chronic Schizophrenia: Optimizing Adherence, Minimizing Burden
Leslie L. Citrome, MD, MPH
Chronic schizophrenia is a debilitating disorder that greatly impacts quality of life. In this presentation, Dr. Leslie Citrome provides information on the importance of adherence to medication for the treatment of schizophrenia. He also discusses how to align long-term treatment plans with patients individual goals, in order to maximize adherence and minimize burden.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Forgotten But Not Gone: New Developments in the Understanding and Treatment of Tardive Dyskinesia
Jonathan M Meyer, MD
Tardive dyskinesia (TD) is an ongoing concern for patients treated with antipsychotics. Symptoms may wax and wane across time, contributing to the clinical challenge of accurately diagnosing TD. In this presentation, Dr. Jonathan Meyer discusses the management of tardive syndromes based on evidence-based guidelines, with emphasis on new developments in treatment options.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Mood Disorders: A "Spectrum" Analysis
Stephen M Stahl, MD, PhD
All too often, the subtle symptoms of hypomania are overlooked during a depressive episode; the consequences of this mistake can be dire for patients. In this presentation, Dr. Stephen Stahl will educate clinicians on best practices for recognizing mixed depression as well as treatment recommendations designed to improve outcomes for patients whose depression does not entirely fall on the strictly unipolar end of the mood spectrum.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Lightning Round Cases: Anxiety
Thomas L Schwartz, MD
Anxiety disorders are one of the most types of mental illnesses. In this presentation, Dr. Thomas Schwartz will discuss the environmental and genetic factors that can contribute to the development of an anxiety disorder, the best practices and guidelines regarding different therapeutic options available for anxiety disorders, including PTSD, and how to develop treatment strategies that maximize outcomes will be discussed through case-based questions.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Lightning Round Cases: Focus on Neurology
Stephen M Stahl, MD, PhD
Oftentimes, neurological disorders have significant psychiatric components. In this lightning round, case-based presentation, Dr. Stephen M. Stahl reviews some of the etiology, diagnosis, and treatment of a variety of neurological conditions including dementia, pseudobulbar affect, multiple sclerosis, epilepsy, and sleep-wake disorders.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Depression-Diabetes-Dementia: A Convergence of Diseases
Roger S McIntyre, FRCPC, MD
Our appreciation for the impact of somatic disorders on mental health, and vice versa, has grown exponentially over the past few years. Here, Dr. Roger McIntyre provides an update on how body weight and cardiometabolic issues may impact, and be impacted by, psychiatric illness, particularly as mediated by inflammation. The potential for ameliorating symptoms of mental illness by considering treatment strategies that may influence weight and cardiometabolic function are also discussed.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Neuropsychiatric Symptoms of Parkinson's Disease
Daniel Weintraub, MD
Although Parkinson's disease is most commonly thought of as a movement disorder, most patients exhibit neuropsychiatric symptoms as well. In this presentation, Dr. Daniel Weintraub discusses various non-motor symptoms of Parkinson's disease, including their identification and treatment.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
If at First You Don't Succeed: Individualizing Care for Patients With Inadequate Outcomes on Antidepressant Treatment
David W Goodman, MD
Only a portion of patients with major depressive disorder will adequately respond to their initial antidepressant treatment. In this presentation, Dr. David Goodman expands on therapeutic options, both old and new, for patients with treatment-resistant major depressive disorder.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Beyond P450—Understanding the Role of PGP Transport in CNS Drug Response
Jonathan M Meyer, MD
Drug interactions can result in unwanted side effects, and reduce the effectiveness of a medication. In this presentation, Dr. Jonathan Meyer provides the most current research on P-glycoprotein (PGP) transporter polymorphisms and psychotropic drug response, analyzes the genetics and function of the PGP transporter, and discusses the most relevant literature on PGP-drug interactions.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Marijuana: Substance of Abuse or Therapeutic Option?
William M Sauvé, MD
In 1970, marijuana was classified as a Schedule I drug by the US Substance Abuse Act, criminalizing its personal use and restricting access for research purposes. Despite that fact, in 1996 California became the first state to legalize the sale and use of marijuana for medical purposes; today 25 states and Washington DC have legalized medical marijuana. So where does this leave health care professionals? In this presentation, Dr. William Sauvé discusses the widespread role of the endocannabinoid system, the potential effects—both positive and negative—of exogenous cannabinoids on the body and brain, and the state of the evidence regarding their therapeutic potential in mental health and other conditions.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|